Target
Isocitrate dehydrogenase [NADP] cytoplasmic
Ligand
BDBM377574
Substrate
n/a
Meas. Tech.
ChEMBL_1859393 (CHEMBL4360249)
IC50
213±n/a nM
Citation
 Lin, JLu, WCaravella, JACampbell, AMDiebold, RBEricsson, AFritzen, EGustafson, GRLancia, DRShelekhin, TWang, ZCastro, JClarke, AGotur, DJosephine, HRKatz, MDiep, HKershaw, MYao, LKauffman, GHubbs, SELuke, GPToms, AVWang, LBair, KWBarr, KJDinsmore, CWalker, DAshwell, S Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors. J Med Chem 62:6575-6596 (2019) [PubMed]  Article 
Target
Name:
Isocitrate dehydrogenase [NADP] cytoplasmic
Synonyms:
Cytosolic NADP-isocitrate dehydrogenase | IDH | IDH1 | IDHC_HUMAN | IDP | Isocitrate Dehydrogenase (IDH1) | Isocitrate dehydrogenase 1 (IDH1) | NADP(+)-specific ICDH | Oxalosuccinate decarboxylase | PICD
Type:
Protein
Mol. Mass.:
46661.29
Organism:
Homo sapiens (Human)
Description:
O75874
Residue:
414
Sequence:
MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL
  
Inhibitor
Name:
BDBM377574
Synonyms:
4-{[(1S)-1-(6-chloro-2-oxo- | US10266495, Compound I-2
Type:
Small organic molecule
Emp. Form.:
C19H16ClN3O2
Mol. Mass.:
353.802
SMILES:
COc1cc(N[C@@H](C)c2cc3cc(Cl)ccc3[nH]c2=O)ccc1C#N |r|
Structure:
Search PDB for entries with ligand similarity: